Tag: Drugs and Pharmaceuticals

PITTSBURGH, Pa., Feb. 16, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.

COLUMBUS, Ohio, Nov. 2, 2017 (SEND2PRESS NEWSWIRE) -- ScriptDrop, a healthcare technology company providing medication reminders and deliveries while fighting prescription abandonment and abuse, today announced that it will be featured on "The Success Files" hosted by Rob Lowe, airing on MSNBC and PBS in 2018.

PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

SAN DIEGO, Calif., June 12, 2017 (SEND2PRESS NEWSWIRE) -- ChemDiv Inc., a fully integrated California-based CRO, announced today that Arcus Biosciences selected ChemDiv as the sole source of molecules for Arcus's growing HTS screening collection. This collaboration, which utilized Arcus's medicinal chemistry knowledge and ChemDiv's computational and synthetic chemistry expertise, has resulted in the selection of several hundred thousand structures from which Arcus expects to identify starting points for several of the discovery programs in its portfolio.

FERNLEY, Nev., June 8, 2017 (SEND2PRESS NEWSWIRE) -- Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.

SAN FRANCISCO, Calif. and HOUSTON, Texas, May 16, 2017 (SEND2PRESS NEWSWIRE) -- EPIC Insurance Brokers & Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that Reba Mathew Pharm.D., R.Ph has joined the firm's Employee Benefits Consulting Practice as Pharmacy Practice Director.

IRVING, Texas, April 19, 2017 (SEND2PRESS NEWSWIRE) - BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.

PITTSBURGH, Pa., April 18, 2017 (SEND2PRESS NEWSWIRE) -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.

CORTE MADERA, Calif., March 31, 2017 (SEND2PRESS NEWSWIRE) -- Dr. Don Harte, chiropractic activist, says Trump's new panel, headed by Chris Christie, to deal with the opioid epidemic, is "philosophically and scientifically dead wrong." Dr. Harte declares, "The reason for this epidemic is clear. Orthopedists and other doctors freely prescribe Oxycontin, Fentanyl, Soma and other opioid drugs, get their patients addicted."

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc. (Paragon), announces a monumental ruling handed down by the United States Patent and Trademark Office affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

GRAND RAPIDS, Mich., and ZURICH, Switzerland, Sept. 29, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces a partnership with Heinlein Plastik-Technik GmbH to bring RFID smart packaging solutions to the European cap and closure marketplace. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.

PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

NEW YORK, N.Y., Aug. 2, 2016 (SEND2PRESS NEWSWIRE) -- Eularis announces the release of their one-day Masterclass "Using Artificial Intelligence to Transform Sales and Revenue: What Pharma Need to Know." Many Pharma sales and marketing teams do not understand the relevance, nor the critical importance, of AI to achieve stronger results in their roles, and believe it is not relevant to them or their job. This is an incorrect assumption.

SARASOTA, Fla., July 28, 2016 (SEND2PRESS NEWSWIRE) -- The Sarasota Florida attorney commented after a Philadelphia jury returned a verdict of $70 million against Johnson and Johnson for failing to warn of the risks associated for taking Risperdal. The case involved a sixteen-year-old boy who developed breast from the medication prescribed for attention deficit disorder (ADHD).

ATLANTA, Ga., May 11, 2016 (SEND2PRESS NEWSWIRE) -- BioTE(R) Medical, a leader in bioidentical hormone replacement therapy (BHRT), is expanding its nationwide network of certified physicians into the Atlanta, Georgia market this month.

NEW YORK, N.Y., April 1, 2016 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., said today it hopes potentially fatal side effects associated with SGLT2 inhibitor drugs will be reported to consumers faster, since people taking these next-generation diabetes medications deserve to be notified of the health dangers shortly after they have been reported to the U.S. Food and Drug Administration (FDA).

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

GRAND RAPIDS, Mich. and ZURICH, Switzerland, Jan. 26, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces the successful high-volume production launch of the eSeal heat induction solution. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.

IRVING, Texas, Dec. 30, 2015 (SEND2PRESS NEWSWIRE) -- A current BioTE(R) Medical Combat Trauma Treatment Study (in conjunction with the Veterans Advocacy Center (VAC)) is showing promising results in helping veterans suffering from Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI).

NEW YORK, N.Y., Dec. 7, 2015 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., today announced that the firm has expanded the scope of its investigation into SGLT2 inhibitor drug injuries. SGLT2 inhibitor drugs include Invokana and others listed below. This move will allow the nationally known mass tort law and personal injury firm to focus on cases where people taking SGLT2 inhibitors were hospitalized after developing urosepsis (serious infection of the blood) or pyelonephritis (infection of the kidneys) from SGLT2 inhibitor-associated urinary tract infections.